chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever of 37.5 to 38.5 for 6-7 days every evening and night after the vaccine (starting on 03/28 and stopping by 04/02-04/03) + chills, body aches, headache, nausea. Starting 04/03 chest pain and tightness, back pain between shoulder blades, difficulty breathing when going up the stairs, throat and jaw pain, blood pressure higher than usual. Starting 04/06 warm rash on the injection site and itchy bumps on fingers and toes (chilblains).
Early morning had significant vertigo; Headache all day; Have had tinnitus ever since; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Early morning had significant vertigo), TINNITUS (Have had tinnitus ever since) and HEADACHE (Headache all day) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced VERTIGO (Early morning had significant vertigo) and HEADACHE (Headache all day). In November 2021, the patient experienced TINNITUS (Have had tinnitus ever since). At the time of the report, VERTIGO (Early morning had significant vertigo), TINNITUS (Have had tinnitus ever since) and HEADACHE (Headache all day) outcome was unknown.            No concomitant medication information was provided. No treatment medication were provided
Expired vaccine was kept in refrigerator a week before administration; No adverse event; Vaccine expired on 20-May-2022 and was administered on 16-Jun-2022; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022 and was administered on 16-Jun-2022), PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator a week before administration) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022 and was administered on 16-Jun-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator a week before administration) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022 and was administered on 16-Jun-2022), PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator a week before administration) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022 and was administered on 16-Jun-2022) and PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator a week before administration).    Concomitant drugs were not reported.  The patient received second booster dose.  The patient had not reported any adverse reactions.  Number of doses/vials were 7 doses/1 vial.  It was reported that the reporter did not know when the vial was initially stored but states that vaccines were usually put in refrigerator a week before administration.   The vial did not undergo any temperature excursion.  Treatment medications were not provided.
I didn't have any side effects locally after receiving the vaccine, but about a month later I started having irritation in my left eye. I went to the eye doctor and he diagnosed me with chronic giant papillary conjunctivitis. He told me to take Pataday Drops and to decrease wearing my contact lenses until my eye improved. I haven't been wearing my contacts because I have been still having irritation in my eye. I went to another specialist Dr.  She diagnosed it as iris nevus (D31.40) which is a benign neoplasm of the iris and ciliary body. I was informed to come back every six months to have my eye monitored.
Reaction to the last COVID injection; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4444009-00 .  A 71-year-old patient received BNT162b2 (BNT162B2), on 18Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 70 years intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 01, Intramuscular), administration date: 28Jan2021, when the patient was 70-year-old, for COVID-19 Vaccination. The following information was reported: IMMUNISATION REACTION (non-serious) with onset 2021, outcome "unknown", described as "Reaction to the last COVID injection".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
HYPOTENSION 2/26/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Patient has gout; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Patient has gout) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Gout.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GOUT (Patient has gout). At the time of the report, GOUT (Patient has gout) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
rapid heart rate (100 beats per minutes) during April 25 (one day after vaccination).
Patient broke up in hives after the vaccine. Had to get a BENZEDRINE shot at the hospital.
The evening after my vaccine, my arm swelled up and I still have a knot in my arm. My top lip swelled and my throat started to close. I used my EpiPen.
very hot; arm was itchy; a golf ball sized swelling at the injection site; issues; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (issues), VACCINATION SITE WARMTH (very hot), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE SWELLING (a golf ball sized swelling at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE REACTION (issues). On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (very hot), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE SWELLING (a golf ball sized swelling at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; HYDROCORTISONE at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (issues), VACCINATION SITE WARMTH (very hot), VACCINATION SITE PRURITUS (arm was itchy) and VACCINATION SITE SWELLING (a golf ball sized swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported
Patient was given an adult dose of Moderna when she should have received a dose of Pfizer. Moderna adult dose not approved for under 18 years of age
I became extremely sick to my stomach (never vomited), had chills and ached all over. This lasted throughout the night (started almost 12 hours exactly after the shot. When I got up at 6 am I felt like I'd been hit by a truck. By noon I felt fine. This was my second shot and I did not have this type of reaction the first time.
On 16-AUG-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # R004689; expiration date: 29-NOV-2020) or (lot # R006689; expiration date: 29-NOV-2020) (dose and route of administration were not reported) for prophylaxis, which had a temperature excursion of 47°F to 77°F (56F) for 15 days on unspecified dates. There were no previous temperature excursions and no digital data logger involved in recording the temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Sender's Comments: US-009507513-1808USA012996: US-009507513-1809USA006252: US-009507513-1809USA006253: US-009507513-1809USA006255: US-009507513-1809USA006256: US-009507513-1809USA006257: US-009507513-1809USA006258: US-009507513-1809USA006259: US-009507513-1809USA006260: US-009507513-1809USA006261: US-009507513-1809USA006262: DE-009507513- 1805DEU013376: US-009507513-1809USA006251.
Swollen arm where virus entered last week, pain returned after no pain for past 4 days
PATIENT DEVELOPED ITCH RASH/WELTS ON BACK OF BILATERAL THIGH BELOW BUTTOCKS
Patient noted red welt on right arm after injection on 10/3. Patient returned to office afternoon of 10/4 with noted 3.5in red welt on right arm. Patient stated slightly itchy, but denied pain, SOB, fevers.  Patient stated the size of the welt had grown larger since first started on 10/3. Patient instructed to treat with benadryl 50mg Q6H, tylenol or ibuprofen for pain and cool compresses.
Started with itching, then overnight became a rash/hive area with erythema and slight swelling on Day 9 (half-dollar size). Treated with Benadryl (oral) and corticosteroid cream topical.  Affected surface area increasing daily, itching persists but not chronic or bothersome, erythema and swelling persists currently on Day20, surface area now size of cantaloupe, still using corticosteroid cream topically, taking routine Claritin-D + Zyrtec backer due to seasonal allergies, occasional Benadryl dose.
This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Jul2022 at 15:00 as dose 1, single (Lot number: FM7553) at the age of 54 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "depression" (unspecified if ongoing); "PCOS" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "Covid-19", start date: Nov2020 (unspecified if ongoing), notes: I was diagnosed with COVID in Nov2020. Concomitant medication(s) included: PINDOLOL; LEVOTHYROXINE; LISINOPRIL; PRISTIQ. Past drug history included: Thimerosal, reaction(s): "known allergies: Thimerosal", notes: known allergies: Thimerosal. The following information was reported: HEADACHE (non-serious) with onset 17Jul2022, outcome "recovered" (Jul2022), described as "Mild headache"; FATIGUE (non-serious) with onset 18Jul2022 at 12:00, outcome "recovered" (Jul2022); PYREXIA (non-serious) with onset 18Jul2022 at 12:00, outcome "recovered" (Jul2022), described as "LGF 99.3"; FACIAL PAIN (non-serious) with onset 18Jul2022 at 12:00, outcome "recovered" (Jul2022), described as "felt like my face was "on fire""; BACK PAIN (non-serious) with onset 18Jul2022 at 12:00, outcome "recovered" (Jul2022), described as "lower back pain". The events "mild headache", "lower back pain", "lgf 99.3", "felt like my face was "on fire"" and "fatigue" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, back pain, pyrexia, facial pain, fatigue.
severe headache; I have pretty significant and persistent pain in the back of my neck; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 42 year old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 30Jul2021 20:00 (Batch/Lot Number: FA7485) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included crohn's disease from an unknown date and unknown if ongoing, gastrooesophageal reflux disease from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medication(s) included buprenorphine hydrochloride, naloxone hydrochloride (SUBOXONE) taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) taken for an unspecified indication, start and stop date were not reported; hydroxyzine (HYDROXYZINE) taken for an unspecified indication, start and stop date were not reported; mesalamine (MESALAMINE) taken for an unspecified indication, start and stop date were not reported; ondansetron (ZOFRAN [ONDANSETRON]) taken for an unspecified indication, start and stop date were not reported; baclofen (BACLOFEN) taken for an unspecified indication, start and stop date were not reported; naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported. The patient previously took levaquin and experienced hypersensitivity, flexeril [cefixime] and experienced hypersensitivity. The patient experienced severe headache on 30Jul2021 22:00 with outcome of not recovered. Also, significant and persistent pain in the back of her neck on 30Jul2021 22:00 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 02Aug2021.  No follow-up attempts are possible. No further information is expected.
Purple & blue bruising under my skin on L leg, brief itchiness redness and hives that disappeared
Patient was vaccinated for COVID-19 on 1/20/21, 2/11/21 and 10/4/21, so was fully vaccinated when testing positive for COVID-19 on 10/11/21.
pt presented with urticaria  day after vaccination on 2/28/2021 which is persistent now 3/3/2021
pt recv vax & 1-1 1/2hr p/vax w/shaking, chills, pale, hands cool, some cyanosis in fingers rt arm inj given rt) VS 99.2, P72,R16, BP 136/60;passed out;
Pt walked out to waiting room and per mom felt dizzy, she had him sit down and he slumped over and passed out. When I saw pt he was awake, but pale and dizzy. Recovered and walked out of office.
Day after (Friday) - body, head, stomach aches.... even my gums ached. Exhaustion. Day two - body aches and weakness (no food on Friday) Tired. Day three - Tired after walking the dog, napped and then tightness/ache in chest/lung area which continued throughout the night. I could not lie on my side or it would trigger the ache in my chest. I could breathe deeply but that also triggered the tightness. Day four (Monday) - Chest ache continued. Contacted doctor's office. Took a Tylenol that seemed to help a little and watching my blood pressure.
I have noticed that my menstrual cycle has become increasingly heavy and has lasted longer than ever before consistently since receiving the second dose of the vaccine. I have also gotten the booster and again noticed a slightly longer period as well as heavier flow.  I am very regular and can track my periods.
(L) arm swollen, hot,  tender x 1 week. Seen on 6/30/11. Treatment: cool compresses, rest, Ibuprofen 600mg 3 x a day.
This is a retrospective pregnancy case. This 39-year-old female subject was enrolled in an open label study: a prospective, exploratory, cohort study to detect and describe any abnormal pregnancy outcomes in women intentionally or unintentionally vaccinated with BOOSTRIX during pregnancy or within 28 days preceding conception. The subject received the 1st dose of BOOSTRIX (other) .5 ml on 30th September 2014 10:30. The subject received BOOSTRIX at week 28 of the pregnancy and during the third trimester of pregnancy. On 30th September 2014, less than a day after receiving BOOSTRIX, the subject developed pain in arm (Non-serious). Additional event(s) included shoulder discomfort on 30th September 2014, live birth and vaccine exposure during pregnancy. The outcome of pain in arm was recovering/resolving. The outcome(s) of the additional event(s) included shoulder discomfort (recovering/resolving), live birth (unknown) and vaccine exposure during pregnancy (unknown). The pregnancy resulted in a live neonate with no apparent congenital anomaly. On 20th December 2014 after (weeks gestation), the subject gave birth to a (gender) neonate via unknown delivery. It was unknown if the investigator considered the pain in arm, shoulder discomfort, live birth and vaccine exposure during pregnancy to be related to BOOSTRIX. Additional information: The last menstrual period, the LMP, the GA and the Apgar score were not provided. There was no issue with the baby.
About 45 min to 1 hour after shot, she had low grade fever & her hands were red, warm, & little tingly. Next morning, she had headache, sore throat & her BP was high. Two hour later, she was ok (only headache & tired).
One week after receiving this first shot, I woke up to my arm being swollen at the injection site. The swelling grew to about 4-5 inches in diameter during that day. It became swollen to the point of looking like a giant spider bite. The swelling was completely cleared up by 6/14/22. The left arm felt a bit sore when moved as well as some soreness in the armpit.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 26Mar2021 as dose 1, single (Lot number: En6199), in left arm, on 20Apr2021 as dose 2, single (Lot number: En6207), in left arm, on 26Oct2021 as dose 3 (booster), single (Lot number: Fe3590), in left arm and on 12Apr2022 as dose 4 (booster), single (Lot number: Fk9895) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Penicillin" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "herpes simplex2" (unspecified if ongoing); "aneurysm" (unspecified if ongoing); "ascending aorta" (unspecified if ongoing). Concomitant medication(s) included: ACYCLOVIR-MISR, start date: 01Jan2022; METOPROLOL SUCCINATE, start date: 01Jan2022; VYVANSE, start date: 01Jan2022; LOVASTATIN, start date: 01Jan2022, stop date: 24Jul2022; FLUTICASONE, start date: 01Jan2022; AZELASTINE, start date: 01Jan2022; FLOVENT, start date: 01Jan2022; RESTASIS, start date: 22Apr2022; TURMERIC [CURCUMA LONGA], start date: 01Jan2022. Past drug history included: Bactrim, reaction(s): "Drug Allergy"; Lexapro, reaction(s): "Drug Allergy"; Demerol, reaction(s): "Drug Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.
pt recv vax & exp mosquito bite rash began on next AM w/itching;gone by 24hr;
This report described the occurrence of joint pain in a male patient who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The patient's attorney stated that the patient received an unspecified number of injections of Lymerix in the time period between 1998 and 1999 according to the client. Most likely, the vaccinations were administered in 1999. On 9/3/03, the patient's attorney alleged that the patient suffered severe pain of the knees, shoulder, and elbows. The onset of his symptoms is not clear at this time. Treatment and outcomes of the alleged events were not reported.
Medication administration error.  On 2/3/2023 patient came to primary care office to receive vaccinations to enter CNA program. MA thought that patient had already received Covid primary series vaccinations and patient was administered  Pfizer BioNTech bivalent booster.  After reviewing paperwork, MA discovered that patient had not received their primary series Covid vaccinations.  Error reported to myself, RN at clinic and to pharmacist at hospital.  Notification sent to CDC and response received.  Patient's primary provider notified of error.  Patient notified and scheduled to continue with second dose of Pfizer BioNTech Monovalent vaccine to complete her primary series.
Received  booster shot 9am 2/28/2006 Painful Rash on palm of hand 8pm 2/28/2006 Rash became blisters on hand 3/1/06 Rash/blisters spreading, very painful, MD visit diagnosed as Shingles  11:00 am  3/2/06. Reporter wanted to provide lot # for Hep B vax also found out pt received Hep A that day-please correct.
Didn't know if it is important or not but 24 hours after my Booster shot (Covid-19 Vaccine); I had a very intense severe and unusual Nose bleed; This is a spontaneous report from a contactable consumer (patient). A 70-year-old patient of an unspecified gender received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Exp. date: Unknown) on unspecified date as dose 1, single for COVID-19 immunisation and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Exp. date: Unknown) on unspecified date as dose 2, single for COVID-19 immunisation. The patient experienced didn't know if it is important or not but 24 hours after my booster shot (covid-19 vaccine). I had a very intense severe and unusual nose bleed. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected. Batch/lot number not available for BNT162B2
Narrative:  Covid vaccine doses #1 and #2 were given 20 days apart instead of 28 days +/- 4 per manufacturer/CDC recommendations. Dose #1 given 2/21/2021, Dose #2 3/11/2021. Pt reported no side effects from either dose of vaccine.
SIRVA; This spontaneous case was reported by an other health care professional and describes the occurrence of SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION. At the time of the report, SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
This spontaneous report was received from an office manager from the physician's office via a company representative and refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with the third dose of GARDASIL 9 injection in the back of the thigh instead of deltoid muscle of the arm (dose, lot number and expiration date were not reported). The patient did not have any adverse effects. Additional information has been requested.